MIRA
MIRA

MIRA (MIRA) news

Recent news

Fibra Macquarie technical committee says Fibra MTY offer fair

Fibra Macquarie’s technical committee has concluded that the offer from Fibra MTY is fair, marking a key step in the ongoing merger process. The proposed transaction, valued at approximately $6.5 billion, would combine two major real estate investment trusts in Mexico, creating one of the country’s…

AInvest Wire · 1d ago

Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra sells 34.2 mln shares in Korra Holding for EGP 205.3 mln - EGX

Mohamed Aiman Kamal El Din Mohamed Abdul Khaliq Korra has sold 34.2 million shares in Korra Holding (KORA) for a total value of EGP 205.3 million, according to recent data from the Egyptian Exchange . The transaction reflects significant activity in the stock, which has seen a recent decline in…

AInvest Wire · 2d ago

OpenAI to announce safety assessor details in coming weeks

OpenAI has announced plans to disclose further details about its safety assessment framework in the coming weeks, as part of its ongoing efforts to address risks associated with advanced artificial intelligence systems. The company recently formed a Safety and Security Committee, composed entirely…

AInvest Wire · 6d ago

NOL: Contract award for Deepsea Mira

Northern Ocean has secured a multi-country drilling contract for its Deepsea Mira semi-submersible rig with TotalEnergies, which was awarded in December 2022 . The contract, which commenced in June 2023, includes a firm duration of 300 days, with additional extension options of 180 and 90 days.…

AInvest Wire · Oct 2, 2026

Mira Pharmaceuticals - Submits phase 2A protocol for ketamir-2 in CIPN to IRB after FDA review

Mira Pharmaceuticals, Inc. (NASDAQ: MIRA) has submitted its Phase 2a clinical trial protocol for Ketamir-2 in the treatment of chemotherapy-induced peripheral neuropathy (CIPN) to an Institutional Review Board (IRB) following review by the FDA . The protocol outlines the design and objectives of…

AInvest Wire · Sep 17, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.